Phase 1 Randomized, Controlled, Double-blind Study to Compare the Safety and Effectiveness of Hepatitis B Vaccines in Individuals With Renal Impairment, Diabetes Mellitus or Age Greater Than 40 Years
Phase of Trial: Phase I
Latest Information Update: 09 May 2019
Price : $35 *
At a glance
- Drugs Hepatitis B vaccine (Primary) ; ADVAX; Alum
- Indications Hepatitis B
- Focus Adverse reactions
- Sponsors Vaxine
- 06 May 2019 Status changed from active, no longer recruiting to completed.
- 04 May 2018 Status changed from recruiting to active, no longer recruiting.
- 15 Dec 2016 Planned End Date changed from 1 Dec 2017 to 1 Dec 2018.